This study was aimed to evaluate the clinical values of single markers and combination in
the diagnosis, short-term efficacy and recurrence risk assessment of esophageal squamous …

Background The purpose of this study is to evaluate the predictive significance of
preoperative serum level of cytokeratin 19 fragments (Cyfra21-1) and squamous cell …

Objective To study the clinical significance of the novel tumor marker--CYFRA21-1 in
patients with esophageal cancer. Methods The CYFRA21-1 level in serum of 84 patients …

OBJECTIVE: To study the clinical significance of serum CEA, SCC and Cyfra21-1 test in the
diagnosis, prediction of prognosis and postoperative monitor of recurrence in esophageal …

Background The roles of carcinoembryonic antigen (CEA), cytokeratin 19 fragments
(CYFRA21-1) and neuron-specific enolase (NSE) in metastases occurrence and poor …

BACKGROUND While there are reports that CYFRA 21‐1 is a useful tumor marker, to our
knowledge the clinical utility of this marker to detect recurrences for squamous cell …

From January 2018 to May 2018, 108 patients with thoracic esophageal cancer underwent
esophagectomy with two-to three-field lymph node dissection. Serum cytokeratin 19 …

BACKGROUND: CYFRA 21-1 has been reported as a useful tumor marker for esophageal
carcinoma, but little information was reported about the clinicopathologic importance of …

Aim: To evaluate serum soluble fragments of cytokeratin 19 (ie, CYFRA21-1) as a tumor
marker for patients with squamous cell lung carcinoma (SCLC) and oropharynx squamous …

Background Early diagnosis of nasopharyngeal carcinoma (NPC) needs more reliable
biomarkers. The aim of this study was to investigate serum cytokeratin 19 fragment 21.1 …